Colorado-based Enveda, which uses AI to discover new drugs in the natural world, raised a $311M Series E at a $2B valuation, double its valuation a year ago (Marina Temkin/TechCrunch)
Enveda’s new round values the drug-discovery startup at $2 billion.
Techmeme’s note says the Colorado company raised a $311 million Series E. It also says Enveda uses AI to find potential drugs in the natural world. The valuation is twice what it was a year ago. Techmeme's note
Techmeme’s note says the Colorado company raised a $311 million Series E. It also says Enveda uses AI to find potential drugs in the natural world. The valuation is twice what it was a year ago. Techmeme's note
score 8